发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 35 |
| England | 20 |
| Italy | 18 |
| Spain | 17 |
| Israel | 14 |
| Canada | 12 |
| GERMANY (FED REP GER) | 10 |
| Japan | 10 |
| South Korea | 8 |
| CHINA MAINLAND | 6 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| TEL AVIV UNIVERSITY | 13 |
| UNIVERSITY OF LONDON | 10 |
| CIBER - CENTRO DE INVESTIGACION BIOMEDICA EN R... | 7 |
| ABBVIE | 6 |
| HARVARD UNIVERSITY | 6 |
| UNIVERSITY OF BARCELONA | 6 |
| IMPERIAL COLLEGE LONDON | 5 |
| MASSACHUSETTS GENERAL HOSPITAL | 5 |
| UNIVERSITY OF MILAN | 5 |
| CHAIM SHEBA MEDICAL CENTER | 4 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| The conundrum of depression clinical trials: one size do... | 6 |
| Efficacy of adjunctive low-dose cariprazine in major dep... | 6 |
| Long-acting injectable second-generation antipsychotics ... | 5 |
| Analysis of smoking behavior on the pharmacokinetics of ... | 5 |
| Personalized and precision medicine as informants for tr... | 5 |
| The effects of brexpiprazole and aripiprazole on body we... | 5 |
| A systematic review of the operational definitions for a... | 4 |
| Pharmacological treatment of sexual offenders in German ... | 4 |
| Efficacy and acceptability of antidepressants in patient... | 4 |
| Pexacerfont as a CRF1 antagonist for the treatment of wi... | 4 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| J AFFECT DISORDERS | 48 |
| NEUROPSYCH DIS TREAT | 48 |
| J CLIN PSYCHOPHARM | 46 |
| PSYCHIAT RES | 43 |
| FRONT PSYCHIATRY | 41 |
| INT CLIN PSYCHOPHARM | 37 |
| EXPERT OPIN PHARMACO | 34 |
| J PSYCHIATR RES | 34 |
| CURR NEUROPHARMACOL | 33 |
| COCHRANE DB SYST REV | 30 |